In vitro recombination of non-homologous genes can result in gene fusions that confer a switching phenotype to cells.

Regulation of protein activity is central to the complexity of life. The ability to regulate protein activity through exogenously added molecules has biotechnological/biomedical applications and offers tools for basic science. Such regulation can be achieved by establishing a means to modulate the s...

Full description

Bibliographic Details
Main Authors: Richard A Heins, Jay H Choi, Takayuki Sohka, Marc Ostermeier
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3214044?pdf=render
_version_ 1811214215956922368
author Richard A Heins
Jay H Choi
Takayuki Sohka
Marc Ostermeier
author_facet Richard A Heins
Jay H Choi
Takayuki Sohka
Marc Ostermeier
author_sort Richard A Heins
collection DOAJ
description Regulation of protein activity is central to the complexity of life. The ability to regulate protein activity through exogenously added molecules has biotechnological/biomedical applications and offers tools for basic science. Such regulation can be achieved by establishing a means to modulate the specific activity of the protein (i.e. allostery). An alternative strategy for intracellular regulation of protein activity is to control the amount of protein through effects on its production, accumulation, and degradation. We have previously demonstrated that the non-homologous recombination of the genes encoding maltose binding protein (MBP) and TEM1 β-lactamase (BLA) can result in fusion proteins in which β-lactamase enzyme activity is allosterically regulated by maltose. Here, through use of a two-tiered genetic selection scheme, we demonstrate that such recombination can result in genes that confer maltose-dependent resistance to β-lactam even though they do not encode allosteric enzymes. These 'phenotypic switch' genes encode fusion proteins whose accumulation is a result of a specific interaction with maltose. Phenotypic switches represent an important class of proteins for basic science and biotechnological applications in vivo.
first_indexed 2024-04-12T05:59:31Z
format Article
id doaj.art-9ae6c1bd20cb41458274303959148592
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T05:59:31Z
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-9ae6c1bd20cb414582743039591485922022-12-22T03:45:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01611e2730210.1371/journal.pone.0027302In vitro recombination of non-homologous genes can result in gene fusions that confer a switching phenotype to cells.Richard A HeinsJay H ChoiTakayuki SohkaMarc OstermeierRegulation of protein activity is central to the complexity of life. The ability to regulate protein activity through exogenously added molecules has biotechnological/biomedical applications and offers tools for basic science. Such regulation can be achieved by establishing a means to modulate the specific activity of the protein (i.e. allostery). An alternative strategy for intracellular regulation of protein activity is to control the amount of protein through effects on its production, accumulation, and degradation. We have previously demonstrated that the non-homologous recombination of the genes encoding maltose binding protein (MBP) and TEM1 β-lactamase (BLA) can result in fusion proteins in which β-lactamase enzyme activity is allosterically regulated by maltose. Here, through use of a two-tiered genetic selection scheme, we demonstrate that such recombination can result in genes that confer maltose-dependent resistance to β-lactam even though they do not encode allosteric enzymes. These 'phenotypic switch' genes encode fusion proteins whose accumulation is a result of a specific interaction with maltose. Phenotypic switches represent an important class of proteins for basic science and biotechnological applications in vivo.http://europepmc.org/articles/PMC3214044?pdf=render
spellingShingle Richard A Heins
Jay H Choi
Takayuki Sohka
Marc Ostermeier
In vitro recombination of non-homologous genes can result in gene fusions that confer a switching phenotype to cells.
PLoS ONE
title In vitro recombination of non-homologous genes can result in gene fusions that confer a switching phenotype to cells.
title_full In vitro recombination of non-homologous genes can result in gene fusions that confer a switching phenotype to cells.
title_fullStr In vitro recombination of non-homologous genes can result in gene fusions that confer a switching phenotype to cells.
title_full_unstemmed In vitro recombination of non-homologous genes can result in gene fusions that confer a switching phenotype to cells.
title_short In vitro recombination of non-homologous genes can result in gene fusions that confer a switching phenotype to cells.
title_sort in vitro recombination of non homologous genes can result in gene fusions that confer a switching phenotype to cells
url http://europepmc.org/articles/PMC3214044?pdf=render
work_keys_str_mv AT richardaheins invitrorecombinationofnonhomologousgenescanresultingenefusionsthatconferaswitchingphenotypetocells
AT jayhchoi invitrorecombinationofnonhomologousgenescanresultingenefusionsthatconferaswitchingphenotypetocells
AT takayukisohka invitrorecombinationofnonhomologousgenescanresultingenefusionsthatconferaswitchingphenotypetocells
AT marcostermeier invitrorecombinationofnonhomologousgenescanresultingenefusionsthatconferaswitchingphenotypetocells